PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

102, 2022

Laura Antolino et al., Is TP53 Arg72Pro a risk factor for pancreatic cancer in diabetic patients?

101, 2022

Dragana Jugovic et al., Frequency of NRAS gene mutations among the patients with wild type KRAS colorectal cancers in Southern-Eastern Serbia

1612, 2021

Anello Marcello Poma et al., Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19

112, 2021

Maria Letizia Lai., Thyroid cancer in Sardinian pediatric patients: report of 63 cases and a review of the literature

1311, 2021

Simona De Summa et al., A Promising Role of TGF-beta Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report

311, 2021

Caterina De Luca et. al., RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer.

910, 2021

Francesca Signorini et al., Conventional Transbronchial Needle Aspiration (cTBNA) and EBUS-Guided Transbronchial Needle Aspiration (EBUS-TBNA): A Retrospective Study on the Comparison of the Two Methods for Diagnostic Adequacy in Molecular Analysis

2909, 2021

Giuseppe Sberna et al., Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19

2309, 2021

Paola Ulivi et al., Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience

2109, 2021

Carla Debernardi et al., Correction to: Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction

109, 2021

Carlotta Antoniotti et al., Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study

2508, 2021

Valentina Guarnieri et. al., PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype.

Previous 121314 Next